1 |
Strigl S, Kutlin A, Roblin PM, et al. Is there an association between Kawasaki disease and Chlamydia pneumoniae[J]. Infect Dis,2000,181:2103-2105.
|
2 |
Ramanan AV, Baildam EM. Kawasaki disease following meningococcal septicaemia [J]. Arch Dis Child,2002,87:170-171.
|
3 |
Barton M, Melbourne R, Morais P, et al. Kawasaki syndrome associated with group A Streptococcal and Epstein-Barr virus coinfections [J]. Ann Trop Pediatr, 2002, 22:257-260.
|
4 |
Wang JN, Wang SM, Liu CC, et al. Mycoplasma pneumoniae infection associated with Kawasaki disease [J]. Acta Pediatr, 2001,90:594-595.
|
5 |
Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment,and longterm management of Kawasaki disease: A statement for health professionals from the Committee on Rheumatic Fever, Endocarditis,and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association [J]. Pediatrics,2004,114:1708-1733.
|
6 |
Hu YM, Jiang ZF. Zhu Fu-tang textbook of pediatrics. 7th ed[M]. Beijing: People's Medical Publishing House, 2002, 698-705.
|
7 |
Sengler C, Gaedicke G, Wahn U, et al. Pulmonary symptoms in Kawasaki disease [J]. Pediatr Infect Dis J, 2004, 23(8):782-784.
|
8 |
Biezeveld MH, Kuipers IM, Geissler J, et al. Association of mannose-binding lectin genotype with cardiovascular abnormalities in Kawasaki disease [J]. Lancet, 2003, 361:1268-1270.
|
9 |
Rowley AH, Shulman ST, Spike BT, et al. Oligoclonal IgA response in the vascular wall in acute Kawasaki disease[J]. J Immunol, 2001, 166:1334-1343.
|
10 |
Brown TJ, Crawford SE, Cornwall ML, et al. CD8 T lymphocytes and macrophages infiltrate coronary artery aneurysms in acute Kawasaki disease[J]. J Infect Dis, 2001, 184:940-943.
|
11 |
Palmer AL, Walker T, Smith JC. Acute respiratory distress syndrome in a child with Kawasaki disease[J]. South Med J, 2005, 98(10):1031-1033.
|
12 |
Kum WW, Hung RW, Cameron SB, et al. Temporal sequence and functional implications of Ⅴ beta-specific T cell receptor down-regulation and costimulatory molecule expression following in vitro stimulation with the Staphylococcal superantigen toxic shock syndrome toxin-1 [J]. J Infect Dis, 2002, 185:555-560.
|
13 |
Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis treatment and longterm management of Kawasaki disease: A statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki disease, Council on Cardiovascular Disease in the Young, American Heart Association[J]. Circulation, 2004, 110(17):2747-2771.
|
14 |
Voynow JA, Schanberg L, Sporn T, et al. Pulmonary complications associated with Kawasaki disease [J]. J Pediatr, 2000, 140:786-787.
|
15 |
Susanne M, Benseler BW, McCrindle ED, et al. Infections and Kawasaki Disease: Implications for coronary artery outcome[J]. Pediatrics, 2005, 116:760-766.
|